RELATIONSHIP BETWEEN AUC of 5'-DFUR AND TOXICITY OF CAPECITABINE, FLUOROPYRIMIDINE CARBAMATE ANALOGS, AND 5'-DFUR IN MONKEYS, MICE, AND RATS-Reference-Cited by-同舟云学术

RELATIONSHIP BETWEEN AUC of 5'-DFUR AND TOXICITY OF CAPECITABINE, FLUOROPYRIMIDINE CARBAMATE ANALOGS, AND 5'-DFUR IN MONKEYS, MICE, AND RATS

Published:2006 Issue:3 Volume:31 Page:265-285
ISSN:0388-1350
Container-title:The Journal of Toxicological Sciences
language:en
Short-container-title:J. Toxicol. Sci.

Author:

SHINDOH Hidetoshi¹,KAWASHIMA Akira²,SHISHIDO Nobuyuki²,NAKANO Kounosuke¹,KOBAYASHI Kazuko³,HORII Ikuo⁴

Affiliation:

1. Pre-clinical Research Department

2. Safety Assesment Department

3. Research Compliance & Quality Assurance Coordination Department,Research Division,Chugai Pharmaceutical Co.,Ltd.

4. Pfizer Global Research & Debelopment,Nagoya Laboratories,Pfizer Inc.

Publisher

Japanese Society of Toxicology

Subject

Toxicology

Link

http://www.jstage.jst.go.jp/article/jts/31/3/31_3_265/_pdf

Reference30 articles.

1. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin

2. Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

3. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

4. Gieschke, R., Steimer, J.-L. and Reigner, B.G. (1998): Relationships between metrics of exposure to XelodaTM and occurrence of adverse effects. Proc Am Soc Clin Oncol (ASCO), Los Angeles, May 16−19 (abstract).

5. Population pharmacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of Capecitabine and Its Metabolites in Plasma of Egyptian Colorectal Cancer Patients;Analytica;2023-10-01

2. Determination of Capecitabine and its Metabolites in Plasma of Egyptian Colorectal Cancer Patients;2023-02-28

3. Diurnal Changes in Capecitabine Clock-Controlled Metabolism Enzymes Are Responsible for Its Pharmacokinetics in Male Mice;Journal of Biological Rhythms;2023-02-10

4. Circadian Variations in the Pharmacokinetics of Capecitabine in Mice;SSRN Electronic Journal;2022

5. Assessment of Drug–drug Interaction and Optimization in Capecitabine and Irinotecan Combination Regimen using a Physiologically Based Pharmacokinetic Model;Journal of Pharmaceutical Sciences;2021-12